Home > Insider Trading > Filing (0001209191-18-004661)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	Biological Products, (No Disgnostic Substances) (2836)	463656275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1656998	Robert Azelby	C/O 400 Dexter Avenue North Suite 1200 Seattle WA 98109	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-01-17	2,498	$25.29	73,330	No	4	M	Direct
Common Stock	Acquisiton	2018-01-17	26,633	$20.76	99,963	No	4	M	Direct
Common Stock	Disposition	2018-01-17	21,141	$68.10	78,822	No	4	S	Direct
Common Stock	Disposition	2018-01-17	7,990	$69.95	70,832	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-01-17	2,498	$0.00	2,498	$25.29
Common Stock	Stock Option (Right to Buy)	Disposition	2018-01-17	26,633	$0.00	26,633	$20.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,836		2026-11-07	No	4	M	Direct
101,208		2027-02-06	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2017.
1/48th of the shares subject to the option vested and became exercisable on December 8, 2016 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter.
1/48th of the shares subject to the option vested and became exercisable on March 7, 2017 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter.